
Life Science Diplomacy Alliance
Operationalising new opportunities
for cross-border collaboration in healthcare and life sciences.
A non-partisan coalition across trusted allies shaping resilient cooperation.
Shared interests made practical opportunities
Aligned coordination for long-term, resilient research and development initiatives
Native to health and life science, structured by real-world challenges
Non-partisan and no capture
Reciprocal and unbiased across all allied regions
Pre-competitive
Innate continuity
Translating new health and life science technologies from research and incubation to market — especially across borders — requires capabilities that often fall between or across institutional mandates
Replacing uncertainty with candor and action
The LSDA shapes opportunities that otherwise fail between mandates by incorporating key functional areas, policy, and investment from the beginning
Built-in Resiliency
All opportunities are required to plan for four critical risk scenarios to minimize future economic, governance, geopolitical, and technical challenges
Helping individual mandates be fulfilled while contributing to something larger
Aligning regions with complementary strengths
Building on shared goals and within the realities of governance and regulatory boundaries, capabilities are no longer limited by traditional hubs and clusters.
North of America
Boston–Cambridge; NYC/NJ; Philadelphia; Baltimore/DC; Toronto–Waterloo; Montréal
Middle of America
Minneapolis; Chicago; Detroit/Ann Arbor; Cleveland; Pittsburgh; St. Louis; Madison; Alberta
West of America
Texas; Bay Area; San Diego; LA/Orange County; Seattle; Vancouver; Salt Lake; Denver/Phoenix
South of America
Research Triangle; Atlanta; Florida/Miami; Mexico City/Monterrey; São Paulo
New Nordics
Denmark; Sweden; Norway; Finland; Estonia; Latvia; Lithuania; Iceland
DACH
Basel–Zürich; Munich; Rhine-Neckar; Frankfurt; Vienna; German-speaking clusters
Benelux+
Amsterdam/Leiden/Utrecht/Eindhoven; Belgium; Luxembourg; Paris/Lille
Mediterranean
Lyon/Marseille; Barcelona/Madrid; Portugal; Italy; Greece; Cyprus; Malta; Israel
UK & Ireland
London–Oxford–Cambridge; Manchester; Edinburgh/Glasgow; Dublin
CEE
Poland; Czechia; Slovakia; Hungary; Romania; Bulgaria; Slovenia/Croatia; Serbia/Balkans; Ukraine; Moldova; Eastern German nodes
Pacific Allies
Australia; New Zealand; Japan; South Korea; Singapore
Visibility today and into the future.
Working direct across functions
Leaders of innovation centres, risk capital, policymaking, research institutes, and regional clusters have tended to stay siloed. Our provocations and working groups shape the whole bench-to-bedside translational pathway to bring key functions to the forefront from the beginning.
Connections led by real opportunities & capabilities
Members engage in developing opportunities, building collaborations, and leading challenges according to actual capabilities and requirements — not basic transactions.
Explore opportunities| Precision medicine & genomics | Oncology & early detection | Women’s health | Cardiometabolic & renal | Neurology & mental health | Prevention & wellness | |
|---|---|---|---|---|---|---|
| Research & Translation | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement |
| Clinical Validation & Health Systems | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement |
| Policy & Regulatory | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement |
| Capital & Investment | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement |
| Commercialization & Market Access | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement |
| Manufacturing / Supply / Infrastructure / AI | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement | Cross-functional involvement |
FAQ
Good Questions
In-person convenings
Summits create the shared memory. The work continues between them.
Estonian HealthTech Week
Private dinners and working rooms
MedFIT and BioFIT
Come along
